Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Targeted cancer therapies often cause serious skin problems that need careful management.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

PRP did not significantly regrow hair in alopecia areata totalis patients.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Hair transplantation can successfully treat stubborn alopecia areata.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.